Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04BCG
|
||||
| Former ID |
DNC000882
|
||||
| Drug Name |
LLZ16407
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Target and Pathway | |||||
| Target(s) | Mitogen-activated protein kinase kinase kinase 2 | Target Info | Inhibitor | [1] | |
| KEGG Pathway | MAPK signaling pathway | ||||
| Gap junction | |||||
| GnRH signaling pathway | |||||
| NetPath Pathway | IL5 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| TCR Signaling Pathway | |||||
| PANTHER Pathway | B cell activation | ||||
| EGF receptor signaling pathway | |||||
| FGF signaling pathway | |||||
| Pathway Interaction Database | ErbB1 downstream signaling | ||||
| Trk receptor signaling mediated by the MAPK pathway | |||||
| WikiPathways | Insulin Signaling | ||||
| EGF/EGFR Signaling Pathway | |||||
| MAPK Cascade | |||||
| MAPK Signaling Pathway | |||||
| BDNF signaling pathway | |||||
| IL-1 signaling pathway | |||||
| References | |||||
| REF 1 | Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci. 2002 Jan;23(1):40-5. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.